Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed Mar 3, 2014 · 10-K · 62 days after period end · 0001193125-14-080447
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$8.82M | -$62.07M | -$1.41M | — |
| EPS Diluted | -$0.23 | -$2.36 | -$0.06 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 3, 2014 · 62 d after period end
